Roche and the Tamiflu data
27 November 2012 Business
Company position on access to data for antiviral Tamiflu (oseltamivir) tablets could be softening
Arafat exhumed in poisoning probe
27 November 2012 News and Analysis
An international team of scientists are taking samples from the former Palestinian leader's body to try to discover what killed him
News
End of the road for h-index rankings
27 November 2012 News and Analysis
Criticism leads US group to stop collating ranked list of living chemists
Solvay launches €300,000 chemistry prize
26 November 2012 Business
To recognise science that could 'shape tomorrow's chemistry and help human progress’
Protein coat prepares catalyst for cascades
Protected metal complexes can team up with enzymes for multistep reactions
Spotting silicon in graphene, it's dope
Better understanding of impurities is a prelude to putting atom-thin material into compute...
Schiff seals deal with Reckitt
Boards approves $1.4 billion Reckitt offer as Bayer pulls out of running
Record insider trading case hits pharma
US authorities claim that hedge fund manager made illicit gains of $276 million in respons...
Can the UK fund CCS?
EU is offering €1.5 billion in funding but lack of co-ordination with UK scheme threaten...
Features
Up in the air
23 November 2012 
Feature
Philip Ball looks at the recent progress in lithium–air battery research - has it stalled?
BPA: friend or foe?
Nina Notman takes an in-depth look at the ongoing controversy over bisphenol A
Stationary phases move ahead
What’s in those columns? Jon Evans looks at the sophisticated materials in chromatograph...
Podcasts
The Chemistry World Podcast
Monthly news, interviews and discussions on the latest topics in science
Chemistry in its element: compounds
Each week a leading scientist or author tells the story behind a different compound
Blog
Chemistry in its element – tetracycline
28 November 2012
Chemistry in its element – vinegar
21 November 2012
School of (chemistry) rock
20 November 2012
Opinions
In the Pipeline
Full disclosure?
The pharma industry should be more open with its trial data, says Derek Lowe
Totally Synthetic
Pentalenolactone A methyl ester
Paul Docherty revises a reaction he never could quite remember
